Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells

PARP inhibitors have been proposed as a potential targeted therapy for patients with triple-negative (ER-, PR-, HER2-negative) breast cancers. However, it is as yet unclear as to whether single agent or combination therapy using PARP inhibitors would be most beneficial. To better understand the mech...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bajrami, Ilirjana, Kigozi, Asha, Van Weverwijk, Antoinette, Brough, Rachel, Frankum, Jessica, Lord, Christopher J, Ashworth, Alan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: WILEY-VCH Verlag 2012
Onderwerpen:
Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3491838/
https://ncbi.nlm.nih.gov/pubmed/22933245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201201250
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items